Tandem Diabetes Care (TNDM) Research & Development (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Research & Development came in at $46.0 million in Q1 2026, down 8.32% YoY from $50.2 million in Q1 2025, and little changed on a QoQ basis from $46.1 million in Q4 2025.
Tandem Diabetes Care (TNDM) Research & Development (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Research & Development data on file, last reported at $46.0 million in Q1 2026.
- Quarterly Research & Development fell 8.32% year-over-year to $46.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $188.9 million (down 6.86% YoY) and the FY2025 annual result came in at $193.1 million, down 2.9% from the prior year.
- Research & Development steadied at $46.0 million in Q1 2026, from $46.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $52.2 million in Q4 2024 to a low of $33.2 million in Q1 2022.
- A 5-year average of $43.9 million and a median of $46.0 million in 2026 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 84.62% — and 2025, when it fell 11.75%.
- Tracing TNDM's Research & Development over 5 years: stood at $35.6 million in 2022, then increased by 19.72% to $42.6 million in 2023, then climbed by 22.52% to $52.2 million in 2024, then slipped by 11.75% to $46.1 million in 2025, then slipped by 0.07% to $46.0 million in 2026.
- The last three Research & Development figures came in at $46.0 million (Q1 2026), $46.1 million (Q4 2025), and $48.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | 46.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.93 Mn |
| Mar 31, 2026 | 46.04 Mn |
| Dec 31, 2025 | 46.07 Mn |
| Sep 30, 2025 | 48.72 Mn |
| Jun 30, 2025 | 48.12 Mn |
| Mar 31, 2025 | 50.22 Mn |
| Dec 31, 2024 | 52.20 Mn |
| Sep 30, 2024 | 51.11 Mn |
| Jun 30, 2024 | 49.33 Mn |
| Mar 31, 2024 | 46.24 Mn |
| Dec 31, 2023 | 42.60 Mn |
| Sep 30, 2023 | 41.97 Mn |
| Jun 30, 2023 | 42.93 Mn |
| Mar 31, 2023 | 42.16 Mn |
| Dec 31, 2022 | 35.59 Mn |
| Sep 30, 2022 | 36.80 Mn |
| Jun 30, 2022 | 33.57 Mn |
| Mar 31, 2022 | 33.16 Mn |
| Dec 31, 2021 | 29.49 Mn |
| Sep 30, 2021 | 24.10 Mn |